Skip to main content

Month: April 2025

Alpine Banks of Colorado announces financial results for first quarter 2025

GLENWOOD SPRINGS, Colo., April 30, 2025 (GLOBE NEWSWIRE) — Alpine Banks of Colorado (OTCQX: ALPIB) (“Alpine” or the “Company”), the holding company for Alpine Bank (the “Bank”), today announced results (unaudited) for the first quarter ended March 31, 2025. The Company reported net income of $14.3 million, or $133.99 per basic Class A common share and $0.89 per basic Class B common share, for first quarter 2025. Highlights in first quarter 2025 include:Basic earnings per Class A common share increased 3.9%, or $5.07, during first quarter 2025. Basic earnings per Class A common share increased 36.3%, or $35.67, compared to first quarter 2024. Basic earnings per Class B common share increased 3.9%, or $0.03, during first quarter 2025. Basic earnings per Class B common share increased 36.3%, or $0.23, compared to first quarter 2024. Net...

Continue reading

Digital Utilities Ventures Finalizes Full Ownership of Technology Integration Subsidiary

100% ownership of Easy Energy Systems Technologies, LLC supports DUTV’s platform unification and reinforces long-term value strategy MANKATO, Minn., April 30, 2025 (GLOBE NEWSWIRE) — Digital Utilities Ventures, Inc. (OTC: DUTV), now doing business as Easy Environmental Solutions Inc., a leader in regenerative agriculture and clean water technologies, today announced that it now holds 100% ownership of Easy Energy Systems Technologies, LLC, previously a majority-owned subsidiary. Energy Systems Technologies houses key system integration and remote monitoring capabilities that support DUTV’s modular technology platforms, including the Easy NanoVoid™ and Easy FEN™. By unifying full ownership, DUTV has further aligned its operational and technology assets under the public company structure, supporting its transition from...

Continue reading

Rakovina Therapeutics Inc. Announces 2024 Financial Results and Provides Corporate Update

VANCOUVER, British Columbia, April 30, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered drug discovery announced the financial results for its fourth quarter and fiscal year ending December 31, 2024 and provided a corporate update. 2024 Highlights and Recent DevelopmentsOn April 29, 2025, we announced the intention to appoint Yevgeniy Meshcherekov and David Kideckel to the Company’s board of directors, subject to receiving approval from the TSX Venture Exchange. The Company also announces that Michael Liggett has retired from the Board. Subject to TSXV approval, Mr. Meshcherekov will replace Mr. Liggett as the chair of the audit committee of the Board On April 28 & 29, 2025, we presented...

Continue reading

Red River Bancshares, Inc. Reports First Quarter 2025 Financial Results

ALEXANDRIA, La., April 30, 2025 (GLOBE NEWSWIRE) — Red River Bancshares, Inc. (the “Company”) (Nasdaq: RRBI), the holding company for Red River Bank (the “Bank”), announced today its unaudited financial results for the first quarter of 2025. Net income for the first quarter of 2025 was $10.4 million, or $1.52 per diluted common share (“EPS”), an increase of $1.0 million, or 11.2%, compared to $9.3 million, or $1.37 EPS, for the fourth quarter of 2024, and an increase of $2.2 million, or 26.4%, compared to $8.2 million, or $1.16 EPS, for the first quarter of 2024. For the first quarter of 2025, the quarterly return on assets was 1.32%, and the quarterly return on equity was 12.85%. First Quarter 2025 Performance and Operational Highlights The Company had solid financial results for the first quarter of 2025. The net interest margin,...

Continue reading

Total number of shares and voting rights in ROCKWOOL A/S

Company announcementfor ROCKWOOL A/SRelease no. 26 – 2025to Nasdaq Copenhagen         30 April 2025 Total number of shares and voting rights in ROCKWOOL A/S ROCKWOOL A/S (“the Company”) completed a share split in the ratio of 1:10 on 11 April 2025 pursuant to a resolution adopted at the Company’s Annual General Meeting on 2 April 2025. In accordance with Section 32 of the Danish Capital Market Act, the Company is required to disclose the total number of voting rights and shares in the event of changes. Following completion of the share split, the Company’s share capital and total number of voting rights are as follows:  Share capital (nominal value, DKK) Number of shares (of 1 DKK each) Number of votesClass A shares 98,178,390 98,178,390 981,783,900Class B shares 118,028,700 118,028,700 118,028,700Total 216,207,090 216,207,090 1,099,812,600Further...

Continue reading

Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,281,056, Including 58 Claims Covering Various Formulations for its (Z)-endoxifen Portfolio

SEATTLE, April 30, 2025 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today announced that the United States Patent and Trademark Office (USPTO) has granted a new patent (U.S. Patent No. 12,281,056) directed to highly pure and stable enteric oral formulations comprising (Z)-endoxifen as well as therapeutic methods of using those oral formulations. The newly granted patent includes 58 claims covering (Z)-endoxifen formulations, including various levels of purity and stability as well as methods of using those formulations. This patent provides additional support for Atossa’s intellectual property portfolio surrounding its proprietary (Z)-endoxifen formulations, a potent Selective Estrogen Receptor...

Continue reading

VERSES® Announces Commercial Launch of Genius™

Launch to Drive Enterprise Customer Acquisition, Product Adoption and Revenue Growth VANCOUVER, British Columbia, April 30, 2025 (GLOBE NEWSWIRE) — VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) (“VERSES” or the “Company”) a cognitive computing company specializing in next-generation intelligent software systems is pleased to announce that the Company has officially launched its flagship product Genius enabling Agentic Intelligence for Enterprise. The Company will offer Genius as a paid service with consumption-based and performance-based pricing as well as enterprise licenses. “With today’s milestone, the commercial launch of Genius, VERSES transitions from research-led to revenue-driven,” said Gabriel René, Founder and CEO of VERSES. “We are delighted to launch Genius commercially today to our first customers and...

Continue reading

Mama’s Creations Invited to Attend Upcoming Investor Conferences

Management to Showcase Continued Topline Momentum, Operational Strength, and Strategic Initiatives Across a Series of Leading Investment Conferences EAST RUTHERFORD, NJ, April 30, 2025 (GLOBE NEWSWIRE) — Mama’s Creations, Inc. (NASDAQ: MAMA), a leading national marketer and manufacturer of fresh Deli prepared foods, today announced that management was invited to participate in four prominent investor conferences in Spring 2025: the BMO Global Farm to Market Conference, the Craig-Hallum 22nd Annual Institutional Investor Conference, the TD Cowen 9th Annual Future of the Consumer Conference, and the Oppenheimer 25th Annual Consumer Growth Conference. Adam L. Michaels, Chairman and CEO of Mama’s Creations, is scheduled to host one-on-one meetings with institutional investors throughout the duration of each event, as follows: BMO Global...

Continue reading

Voxtur Announces Financial Results for the Year and Quarter Ended December 31, 2024

TORONTO and TAMPA, Fla., April 30, 2025 (GLOBE NEWSWIRE) — Voxtur Analytics Corp. (TSXV: VXTR; OTCQB: VXTRF) (“Voxtur” or the “Company”), a North American technology company creating a more transparent and accessible real estate lending ecosystem, today announced its financial results for the three months and year ended December 31, 2024. The Company’s Audited Consolidated Financial Statements for the year ended December 31, 2024, and the related Management’s Discussion and Analysis (“MD&A”) are available at www.sedarplus.ca and at www.voxtur.com. Financial Results:Continuing Operations Unaudited   Audited  Three months ended December 31   Year ended December 31(In thousands of Canadian dollars)  2024   2023     2024   2023            Revenue 1 $ 9,307   $ 9,886     $ 45,737   $ 48,959  Gross...

Continue reading

PST Group AB has signed a contract with UAB Ekos lc worth EUR 22.95 million for the construction of a commercial building in Kaunas.

PST Group AB has signed a EUR 22.95 million (incl. VAT) contract with UAB Ekos LC, a member of the Kosmelita group of companies, which operates the Eurokos chain of beauty and cosmetics stores, and UAB Statservice, the construction project manager, for the construction of a retail building at Partizanų st. 75, Kaunas, on a land plot adjacent to the A1 trunk road. The total area of the four-storey administrative, retail and warehousing building will be around 22,000 sq. m, with an estimated completion date of 14 months from the date of signing the contract. The aim will be to achieve the highest possible BREEAM In-Use (the standard for assessing the sustainability of existing buildings) rating for an A++ energy performance class building.More information:Tomas Stukas Managing Director Tel.: +370 618 21360

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.